- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1878-7479
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism ; day:10 ; month:9 ; year:2020 ; pages:1-15
Neurotherapeutics ; (10.9.2020), 1-15
- Urheber
-
Schneider, Susanne A.
Hizli, Baccara
Alcalay, Roy N.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13311-020-00920-8
- URN
-
urn:nbn:de:101:1-2020103022261957101211
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schneider, Susanne A.
- Hizli, Baccara
- Alcalay, Roy N.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Androgen receptor function and targeted therapeutics across breast cancer subtypes
Melanoma : Biologically Targeted Therapeutics
Plasmonic Material Engineering for Targeted Therapeutics
Molecular genetic mechanisms surrounding x-linked Dystonia-Parkinsonism
Rethinking medulloblastoma from a targeted therapeutics perspective
Sporadic Parkinsonism
Lysosome‐Targeted Bifunctional Therapeutics Induce Autodynamic Cancer Therapy
Post-dengue parkinsonism
Genetics of Parkinsonism
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP
Progress and challenges towards targeted delivery of cancer therapeutics
Androgen receptor function and targeted therapeutics across breast cancer subtypes
Melanoma : Biologically Targeted Therapeutics
Plasmonic Material Engineering for Targeted Therapeutics
Molecular genetic mechanisms surrounding x-linked Dystonia-Parkinsonism
Rethinking medulloblastoma from a targeted therapeutics perspective
Sporadic Parkinsonism
Lysosome‐Targeted Bifunctional Therapeutics Induce Autodynamic Cancer Therapy
Post-dengue parkinsonism
Genetics of Parkinsonism
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP
Progress and challenges towards targeted delivery of cancer therapeutics
Androgen receptor function and targeted therapeutics across breast cancer subtypes
Melanoma : Biologically Targeted Therapeutics
Plasmonic Material Engineering for Targeted Therapeutics
Molecular genetic mechanisms surrounding x-linked Dystonia-Parkinsonism
Rethinking medulloblastoma from a targeted therapeutics perspective
Sporadic Parkinsonism
Lysosome‐Targeted Bifunctional Therapeutics Induce Autodynamic Cancer Therapy
Post-dengue parkinsonism
Genetics of Parkinsonism
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP